ki-alz
|
|
Idee und PotenzialWe aim to dramatically increase diagnostic accuracy for early-stage Alzheimer’s Disease in primary care and to establish automated high-precision patient-centered monitoring of therapeutic success. We will achieve these ambitious goals by building a multimodal platform, including AI-assisted analysis of MRI atrophy patterns, fluid biomarkers, clinical assessments, and digital biomarkers for use by care providers and service users. |
|
|
GründerInnen
Webauftritt & Kontakt